Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients

Background and Purpose In patients with acute ischemic stroke (AIS) using a direct oral factor-Xa anticoagulant (DOAC) during the last 48 hours, a fixed plasma heparin-calibrated anti-Xa activity (0.5 IU/mL) was proposed as a threshold below which patients could be eligible for thrombolysis and/or t...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Charlyne Brakta, Alain Stépanian, Peggy Reiner, Maxime Delrue, Mikaël Mazighi, Emmanuel Curis, Virginie Siguret
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Korean Stroke Society 2023-01-01
Loạt:Journal of Stroke
Những chủ đề:
Truy cập trực tuyến:http://www.j-stroke.org/upload/pdf/jos-2022-03034.pdf